Covering the latest advances in the field, Dopamine in the Treatment of Schizophrenia, Second Edition provides a detailed explanation of the etiology and clinical presentation of the disease, especially as related to the dopamine system. Written by an international team of experts, the text identifies genetic polymorphisms that affect dopaminergic neurotransmission and their possible impact on familial forms of schizophrenia. It also explores the neurophysiological and neurochemical studies of dopaminergic function and the integration of dopamine-containing neurons with other transmitter systems. It reviews imaging studies and their contribution to our understanding of the pathophysiology of schizophrenia and the mechanism of action of antipsychotics. Finally, the book puts the role of dopamine in the context of other brain systems and highlights the many unmet needs of patients, despite best current treatments.
Auflage
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Neurologists, psychiatrists, pharmacologists, and students in those fields.
Editions-Typ
Illustrationen
82 s/w Abbildungen
82 Illustrations, black and white
Maße
Höhe: 235 mm
Breite: 156 mm
Gewicht
ISBN-13
978-1-84184-304-9 (9781841843049)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Herausgeber*in
Centre for Addiction & Mental Health, Toronto, Ontario, Cana
Historical Aspects and Future Directions
Evidence of Brain Imaging Studies for Dopaminergic Alterations in Schizophrenia
Modulation of Dopamine D^O2
Receptors as a Basis of Antipsychotic Effect
Amisulpride as a Model: Clinical Effects of a Pure Dopaminergic Agent
A Meta-analysis of Studies with the Atypical Antipsychotic Amisulpride
Evidence from Brain Imaging fpr Regional Monoaminergic Specificity in Schizophrenia
Dopamine, the Prefrontal Cortex, and A Genetic Mechanism of Schizophrenia
Models of Schizophrenia: From Neuroplasticity and Dopamine to Psychopathology and Clinical Management
Multiple Neurotransmitters Involved in Antipsychotic Drug Action
Dopaminergic and Glutamatergic Influences in the Systems Biology of Schizophrenia
Pharmacogenomics of Antipsychotic Drugs
Key Issues and Unmet Needs in Schizophrenia
Index